Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
暂无分享,去创建一个
Y. Tabata | M. Fujita | M. Komeda | Sachiko Inoue | M. Mitsuyama | Y. Arai | A. Marui | K. Hirose | T. Nomura | Kozo Kaneda | T. Kamitani
[1] Y. Tabata,et al. Sustained-release form of basic fibroblast growth factor prevents catheter-related bacterial invasion in mice. , 2005, Interactive cardiovascular and thoracic surgery.
[2] M. Ono,et al. Management of Infected Grafts and Aneurysms of the Aorta , 2005, Annals of vascular surgery.
[3] A. D. Ammar,et al. The Incidence of Ischemic Stroke versus Intracerebral Hemorrhage after Carotid Endarterectomy: A Review of 2452 Cases , 2005, Annals of vascular surgery.
[4] M Fini,et al. New polymers for drug delivery systems in orthopaedics: in vivo biocompatibility evaluation. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] L. Napolitano,et al. Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. , 2004, Surgical infections.
[6] C. Gabka,et al. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[7] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[8] M. V. van Sambeek,et al. Management of aortic graft infection. , 2002, The Journal of cardiovascular surgery.
[9] John Samuel,et al. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.
[10] A Odero,et al. Vascular prosthetic Graft Infection: Epidemiology, Bacteriology, Pathogenesis and Treatment , 2002, Acta chirurgica Belgica.
[11] Steven P Schwendeman,et al. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.
[12] A. Naylor,et al. The impact of MRSA on vascular surgery. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[13] S. Wilson. New alternatives in management of the infected vascular prosthesis. , 2001, Surgical infections.
[14] J. Hallett,et al. The results of in situ prosthetic replacement for infected aortic grafts. , 1999, American journal of surgery.
[15] H. Bruch,et al. Local application of vancomycin for prophylaxis of graft infection: Release of vancomycin from antibiotic-bonded dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model , 1996, Annals of vascular surgery.
[16] J. Labarca,et al. Pharmacokinetics of vancomycin in patients with severely impaired renal function. , 1996, International journal of clinical pharmacology and therapeutics.
[17] J. Peyton,et al. The natural history of bacterial biofilm graft infection. , 1994, The Journal of surgical research.
[18] F. Veith,et al. Diagnosis and management of infected prosthetic aortic grafts. , 1991, Surgery.